AMPA receptor modulator-2
|
A651137-100mg
|
≥99% |
2034181-36-5 |
100mg
|
¥ 28500.9
|
期货,请咨询 |
阿拉丁 |
Albendazole sulfoxide-d3
|
A651113-5mg
|
≥99% |
1448346-38-0 |
5mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
AZD2423
|
A651097-5mg
|
≥98% |
1229603-37-5 |
5mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
AZD2423
|
A651097-10mg
|
≥98% |
1229603-37-5 |
10mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
Aposcopolamine
|
A651081-5mg
|
≥98% |
535-26-2 |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Aposcopolamine
|
A651081-10mg
|
≥98% |
535-26-2 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
(1S,2R)-Alicapistat
|
A651080-5mg
|
≥98% |
2221010-57-5 |
5mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
(1S,2R)-Alicapistat
|
A651080-10mg
|
≥98% |
2221010-57-5 |
10mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
Astragaloside VI
|
A651074-5mg
|
≥99% |
84687-45-6 |
5mg
|
¥ 5390.9
|
期货,请咨询 |
阿拉丁 |
A2AR-agonist-1
|
A651043-5mg
|
≥99% |
41552-95-8 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
A2AR-agonist-1
|
A651043-50mg
|
≥99% |
41552-95-8 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
A2AR-agonist-1
|
A651043-1mg
|
≥99% |
41552-95-8 |
1mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
A2AR-agonist-1
|
A651043-10mg
|
≥99% |
41552-95-8 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
A2AR-agonist-1
|
A651043-100mg
|
≥99% |
41552-95-8 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
Ac-WLA-AMC
|
A651030-5mg
|
|
1104011-59-7 |
5mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
Ac-WLA-AMC
|
A651030-1mg
|
|
1104011-59-7 |
1mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Ac-WLA-AMC
|
A651030-10mg
|
|
1104011-59-7 |
10mg
|
¥ 5100.9
|
期货,请咨询 |
阿拉丁 |
AMG 511
|
A651027-5mg
|
≥99% |
1253573-53-3 |
5mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
AMG 511
|
A651027-25mg
|
≥99% |
1253573-53-3 |
25mg
|
¥ 9400.9
|
期货,请咨询 |
阿拉丁 |
AMG 511
|
A651027-1mg
|
≥99% |
1253573-53-3 |
1mg
|
¥ 838.9
|
期货,请咨询 |
阿拉丁 |
AMG 511
|
A651027-10mg
|
≥99% |
1253573-53-3 |
10mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
Acetylene-linker-Val-Cit-PABC-MMAE
|
A651004-5mg
|
≥95% |
1411977-95-1 |
5mg
|
¥ 3650.9
|
期货,请咨询 |
阿拉丁 |
Acetylene-linker-Val-Cit-PABC-MMAE
|
A651004-10mg
|
≥95% |
1411977-95-1 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
β-Aspartylaspartic acid
|
A651001-50mg
|
≥95% |
60079-22-3 |
50mg
|
¥ 3400.9
|
期货,请咨询 |
阿拉丁 |